Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI)

• मुख्य लेखकों: Catherine H. Vu (लेखक), Veena Venugopalan (लेखक), Barbara A. Santevecchi (लेखक), Stacy A. Voils (लेखक), Reuben Ramphal (लेखक), Kartikeya Cherabuddi (लेखक), Kathryn DeSear (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Cambridge University Press, 2022-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Objective: To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (ESBL-E BSIs). Design: Retrospective cohort study. Setting: Tertiary-care, academ...